Evaluation of Telerehabilitation Following Inpatient or Outpatient Rehabilitation Phase II

August 9, 2022 updated by: Pensionsversicherungsanstalt

Evaluation Der Telerehabilitation im Anschluss an Eine stationäre Oder Ambulante Rehabilitation Phase II - Pilotprojekt [Evaluation of Telerehabilitation Following Inpatient or Outpatient Rehabilitation Phase II - Pilot Project]

Telerehabilitation is implemented in the Pensionsversicherungsanstalt (PVA) as an independent rehabilitation offer following a rehabilitation phase II. This offer primarily includes physiotherapeutic training units in group settings and in individual counselling, as well as health-related educational sessions and doctor's consultations via video conferencing, initially for rehabilitation patients with diseases of the musculoskeletal system or oncological diseases. The first stage of the implementation process was evaluated with a focus on acceptance, usability and feasibility from the perspective of patients and treatment team.

The evaluation was based on a convergent mixed methods design (Creswell & Plano Clark, 2017) to draw on the strengths of qualitative and quantitative research approaches (Creswell & Creswell, 2018). Qualitative and quantitative data were generated in parallel and treated equally. The perspective of the patients (N = 86) was collected through online questionnaires and in-depth telephone interviews (N = 22) and that of the treatment team through a questionnaire survey (N = 32) and focus group interviews (N = 24). The administrative team (N = 8) was asked for their assessment in a focus group interview. Technical difficulties in the implementation of telerehabilitation were documented by the treatment team. The consolidation of these multi-perspective results took place at the level of interpretation.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

126

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Styria
      • Graz, Styria, Austria, 8020
        • PVA - Zentrum für ambulante Rehabilitation Graz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who have completed rehabilitation phase II and have been assessed by their doctor as suitable for telerehabilitation. Involved treatment team and administrative team.

Description

Inclusion Criteria:

Patients who have completed rehabilitation (phase II) with the indications:

  • musculoskeletal diseases
  • oncology.

Exclusion Criteria:

  • Failure to obtain the declaration of consent
  • Lack of the required technical aids (mobile phone, tablet or PC)
  • Lack of the technical skills to operate the app and thus to participate in telerehabilitation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usability of the telerehabilitation
Time Frame: April 2021 - May 2022

The patients' perspective was collected with a self-developed online questionnaire (N = 86) and in-depth telephone interviews (N = 22).

The questionnaires were analysed descriptively. The telephone interviews were protocolled and subsequently coded and categorised.

The perspective of the treatment team was collected with a self-developed questionnaire (N = 32) and focus group interviews (N = 24).

In addition, the administrative team (N = 8) was asked for their assessments in a focus group interview. The questionnaires were analysed descriptively. The focus group interview was recorded and subsequently coded and categorised.

April 2021 - May 2022
Feasibility of the telerehabilitation
Time Frame: April 2021 - May 2022
Technical difficulties concerning the video calls were continuously documented by the treatment team. The data were analysed descriptively.
April 2021 - May 2022
Acceptance of the telerehabilitation
Time Frame: April 2021 - May 2022

The patients' perspective was collected with a self-developed online questionnaire (N = 86) and in-depth telephone interviews (N = 22).

The questionnaires were analysed descriptively. The telephone interviews were protocolled and subsequently coded and categorised.

The perspective of the treatment team was collected with a self-developed questionnaire (N = 32) and focus group interviews (N = 24).

The questionnaires were analysed descriptively. The focus group interviews were recorded and subsequently coded and categorised.

April 2021 - May 2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: David Felder, Mag., Pensionsversicherungsanstalt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 8, 2021

Primary Completion (Actual)

March 31, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

August 5, 2022

First Submitted That Met QC Criteria

August 5, 2022

First Posted (Actual)

August 9, 2022

Study Record Updates

Last Update Posted (Actual)

August 12, 2022

Last Update Submitted That Met QC Criteria

August 9, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0002 Evaluation Telereha

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Diseases

3
Subscribe